Benfotiamine and ALS
A new study about benfotiamine's use as a therapeutic for ALS patients who studies show often have low thiamine levels.
I feel quite fortunate to have introduced benfotiamine to the American medical community some 17 years ago. Since that time, it has been used to improve neurological function in the feet and legs of thousands of people. I have frequently heard of individuals who–while using benfotiamine for their lower extremity neurological symptoms–have experienced improvement in symptoms unrelated to their lower extremity neuropathy.
I've written a paper on the most interesting of these cases, a gentleman with ALS. Cureus, a highly respected peer reviewed journal, just published it. I am very proud of this work and would like to share it with my colleagues.
The paper can be found at: https://www.cureus.com/articles/157487-impaired-thiamine-metabolism-in-amyotrophic-lateral-sclerosis-and-its-potential-treatment-with-benfotiamine-a-case-report-and-a-review-of-the-literature
Originally published at drrichardhmann.com.
Keep reading
Richard Mann, DPM, Publishes Case Series on Nutritional Approach Using Benfotiamine in Long COVID Brain Fog
Read more
Polyneuropathy, Alzheimer’s Disease and Benfotiamine: Neurodegeneration and Vitamin B1 Deficiency
Read more